Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A Noninvasive Comparison Study between Human Gliomas with IDH1 and IDH2 Mutations by MR Spectroscopy

Shen X. et al, (2019), Metabolites, 9, 35 - 35

A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER

Berrington A. et al, (2018), NMR in Biomedicine, 31, e3886 - e3886

Recent advances in molecular pathology of craniopharyngioma

Larkin S. and Karavitaki N., (2017), F1000Research, 6, 1202 - 1202

Development and Microscopic Anatomy of the Pituitary Gland

Larkin SJ. and Ansorge O., (2017)

Pathology and Pathogenesis of Pituitary Adenomas and Other Sellar Lesions

Larkin SJ. and Ansorge O., (2017)

Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study

Iacovazzo D. et al, (2016), Acta Neuropathologica Communications, 4

Improved Localization for 2-Hydroxyglutarate Detection at 3 T Using Long-TE Semi-LASER

(2016), Tomography, 2, 94 - 105

Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations

Emir UE. et al, (2016), Cancer Research, 76, 43 - 49

The Wnt Signalling Cascade and the Adherens Junction Complex in Craniopharyngioma Tumorigenesis

Preda V. et al, (2015), Endocrine Pathology, 26, 1 - 8

Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas

Larkin SJ. et al, (2014), European Journal of Endocrinology, 171, 705 - 710

Rathke's cleft cyst

Larkin SJ. and Karavitaki N., (2014), Clinical Neuroendocrinology

BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma

Larkin SJ. et al, (2014), Acta Neuropathologica, 127, 927 - 929

Mutations in BRAF and CTNNB1 Genetically Distinguish Papillary and Adamantinomatous Craniopharyngiomas

Larkin SJ. et al, (2014), ENDOCRINE REVIEWS, 35

Rathke's cleft cyst

Larkin S. et al, (2014), 255 - 269

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas

Larkin S. et al, (2013), European Journal of Endocrinology, 168, 491 - 499

Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas

Larkin SJ. et al, (2013), NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 39, 50 - 51

Pathology and pathogenesis of craniopharyngiomas

Larkin SJ. and Ansorge O., (2013), Pituitary, 16, 9 - 17

Pathology and pathogenesis of craniopharyngiomas

Larkin SJ. and Ansorge O., (2013), Pituitary, 16, 9 - 17

Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance

Thornalley PJ. et al, (2010), Nucleic Acids Research, 38, 5432 - 5442

Reversal of Hyperglycemia-Induced Angiogenesis Deficit of Human Endothelial Cells by Overexpression of Glyoxalase 1In Vitro

Ahmed U. et al, (2008), Annals of the New York Academy of Sciences, 1126, 262 - 264

Include forthcoming?